Kabra Drugs standalone net profit declines 33.33% in the September 2016 quarter

Sales rise 17.35% to Rs 2.30 crore

Net profit of Kabra Drugs declined 33.33% to Rs 0.02 crore in the quarter ended September 2016 as against Rs 0.03 crore during the previous quarter ended September 2015. Sales rose 17.35% to Rs 2.30 crore in the quarter ended September 2016 as against Rs 1.96 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales2.301.96 17 OPM %3.484.59 -PBDT0.080.09 -11 PBT0.020.03 -33 NP0.020.03 -33

Powered by Capital Market - Live News